High altitude reduces infection rate of COVID-19 but not case-fatality rate
MetadataShow full item record
Coronavirus disease 19 (COVID-19) is a pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is suggested that life at high altitude may reduce COVID infections and case-fatality rates (cases/deaths). We study data from Peru COVID-19 pandemics, which first case was recorded on March 6th, 2020. By June 13, 2020 there were 6498 deaths, and 224,132 SARS-CoV-2 positives. Using data from 185 capitals of provinces with altitudes ranging from 3 to 4342¿m, we confirm previous reports that infection with COVID-19 at high altitude is reduced. However, case-fatality rate is not dependent of altitude. We have also presented first evidence that female protection towards death by COVID-19 is reduced as altitude of residence increases.
How to citeSegovia-Juarez, J., Castagnetto-Mizuaray, J. M. & Gonzales, G. F. (2020). High altitude reduces infection rate of COVID-19 but not case-fatality rate. Respiratory Physiology & Neurobiology. https://doi.org/10.1016/j.resp.2020.103494
Category / SubcategoryPendiente / Pendiente
xmlui.dri2xhtml.METS-1.0.item-journalRespiratory Physiology & Neurobiology
Indexado en Scopus
The following license files are associated with this item: